INFIXION BIOSCIENCE

iNFixion's unique approach to NF1 is to correct a key underlying genetic ‘mechanism of action', namely the lack of functional Neurofibromin protein, by enhancing the affected person's natural ability to both produce and maintain healthy Neurofibromin protein. By correcting this root cause mechanism, we believe that a fundamental and preventive impact on disease symptoms, and disease progression, will be achieved... A drug discovery company dedicated to developing treatments for Neurofibromatosis Type 1

Also known as: Infixion

Primary location: San Diego United States